September 14, 2017 / 6:28 AM / in 2 months

BRIEF-Astrazeneca says Aspen acquires remaining rights to AZ anaesthetics

Sept 14 (Reuters) - Astrazeneca Plc:

* ASPEN ACQUIRES REMAINING RIGHTS TO AZ ANAESTHETICS

* ENTERED AGREEMENT WITH ASPEN GLOBAL; AGI TO ACQUIRE RESIDUAL RIGHTS TO ESTABLISHED ANAESTHETIC MEDICINES

* UUNDER NEW AGREEMENT, AGI WILL NO LONGER PAY ROYALTIES TO ASTRAZENECA​

* AGI TO BUY REMAINING RIGHTS TO INTELLECTUAL PROPERTY; MANUFACTURING KNOW- HOW RELATED TO ANAESTHETIC MEDICINES FOR UPFRONT CONSIDERATION OF $555 MILLION

* ‍NEW, ADDITIONAL AGREEMENT IS EXPECTED TO CLOSE IN Q4 OF 2017, DOES NOT IMPACT ASTRAZENECA‘S FINANCIAL GUIDANCE FOR 2017​

* AGI TO PAY ASTRAZENECA UP TO $211 MLN IN PERFORMANCE-RELATED MILESTONES BASED ON SALES; GROSS MARGIN DURING PERIOD FROM 1 SEPT TO 30 NOV 2019

* ASTRAZENECA WILL CONTINUE TO MANUFACTURE AND SUPPLY MEDICINES TO AGI DURING A TRANSITION PERIOD OF UP TO FIVE YEARS Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below